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Retinoblastoma: Presentation, 
Evaluation, and Diagnosis
Spencer T. Langevin and Brian P. Marr
Abstract
Retinoblastoma was initially described in a case series by Dr. James Wardrop in 
1809. Since then, the evaluation and diagnosis of retinoblastoma has progressed 
significantly, thus providing a framework for successful therapy with up to 97% 
survival rate in developed nations. Here we outline the presentation, evaluation, 
and detailed diagnostic steps of any child presenting with signs and symptoms 
of retinoblastoma (RB). We detail the questions and pertinent history to obtain, 
describe in detail the examination under anesthesia, ancillary testing, and recom-
mendations for both anesthesia and neuroimaging. We also cover the differential 
diagnosis of retinoblastoma and the most common simulating lesions to present 
to an ophthalmologist. We describe the ways to determine if a patient has retino-
blastoma or some simulating lesion, and the characteristics associated with each 
possibility. Finally, we briefly address genetic counseling and the next steps after 
diagnosis.
Keywords: retinoblastoma, intraocular tumors, oncology, children,  
b-scan ultrasonography, leukocoria, evaluation, diagnosis
1. Introduction
Pawius of Amsterdam is the first physician credited with recognizing retinoblas-
toma in the autopsy of a young child in 1597 [1]. In 1809, a Scottish surgeon from 
Edinburgh, James Wardrop, published a monograph entitled “Observations on the 
fungus haematodes, or soft cancer, in several of the most important organs of the human 
body”. His monograph included clinical histories of 15 children diagnosed with an 
intraocular tumor at the age of 1–6 years [2]. Dr. Wardrop described the tumors as 
“white in colour and brain-like in substance”, and he concluded as well that they 
were of retinal origin. He even went so far as to recommend enucleation to save 
the life of the children, in which his peers did not agree with him at the time. The 
first case in American literature was by Dr. Steven at New York Hospital in 1818 [3]. 
At the time, retinoblastoma was known at fungus haematodes which was initially 
described by Dr. Hey of Leeds, England [4]. Virchow in 1845 renamed the entity 
glioma of the retina [5]. Hirschberg further described the glioma into exophytum 
and endophytum [6]. Flexner described the histologic findings of cellular rosettes 
in the tumor in 1891 [7]. In 1897, Wintersteiner described the lumen of the rosette 
[8]. Finally Verhoeff named the tumor retinoblastoma which was adopted by the 
American Ophthalmological Society in 1926, thus arriving at the terminology we 
use to this day [9].
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2. Presentation, evaluation, and diagnosis
2.1 Clinical presentation
The initial signs and symptoms of retinoblastoma (RB) are usually noticed by 
friends or family members, or at times from an abnormal “red reflex”, more specifi-
cally, a white reflex or (leukocoria) from a photograph. Medical professionals, such 
as pediatricians during a routine examination, or a pediatric ophthalmologist, may 
also notice signs and symptoms consistent with RB, however less often. In very 
rare circumstances the intraocular mass may be picked up on head imaging for 
non-ophthalmic reasons. In developed nations such as the United States, the most 
common presenting finding for intraocular retinoblastoma is leukocoria or “cats 
eye reflex” (43%), followed by strabismus (22%), pseudo cellulitis, (9%), microph-
thalmia (5%), routine screening examination (17%), and rarely the presence of an 
intraocular mass on non-ophthalmic imaging (<1%) [10].
On average the ophthalmic oncologist is the third medical professional to 
evaluate a child suspicious for having RB. According to a large study on referral 
patterns there is an average delay of 1.1 months between initial symptoms and 
evaluation with any medical professional, and 2.0 months before an appointment 
with an ophthalmic oncologist [10]. As of 2014, mortality from retinoblastoma in 
the United States is approximately 3%, however in developing countries is close 
to 60%. Although our treatment has improved greatly, in many parts of the world 
access to care is a large barrier to successful therapy. Mean age at diagnosis in Asia 
is 22 months, compared to North America and Europe which are 12 and 9 months, 
respectively. On a more significant note, there are approximately 3000 new cases 
of retinoblastoma in Asia compared to only 300 new cases in North America, even 
further highlighting the need for improved access to care. As there are relatively 
few specialists and centers who treat such a rare condition, it is important to use 
the internet, telemedicine, and other social services to help train ancillary staff and 
improve access to triage services to improve prognosis for children.
2.2 Misdiagnosis and differential diagnosis
A review of the literature demonstrates a historic misdiagnosis rate of 
11–40% based on histopathologic analysis of enucleated specimens, and a clini-
cal misdiagnosis rate from 16 to 53% [10]. Fortunately the accuracy in diagnosis 
at specialized ophthalmic oncology centers in the United States is believed to 
exceed 99%. In a recent review of referring physician patterns the most common 
simulating lesions (>5% of analyzed lesions) were: Persistent fetal vasculature, 
Coat’s Disease, Astrocytic Hamartoma, Intraretinal hemorrhage, and retinal 
detachment. Retinopathy of prematurity and congenital cataract were previously 
misdiagnosed often, but increased awareness of these conditions and better 
examination practices are likely the cause of reduced misdiagnosis of these two 
entities. Misdiagnosis of RB may be due to the fact that the condition is exceed-
ingly rare, large differential diagnosis, and the challenges of examining children. 
Thus, any suspicion for the condition should warrant prompt referral to special-
ized care [11].
2.3 Evaluation and diagnosis of retinoblastoma
We will describe an organized approach in a stepwise manner for evaluating 
and properly diagnosis of RB. This will consist of: detailed history, initial office 
examination, ultrasonographic testing, examination under anesthesia, and current 
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consensus on imaging and genetic testing. Modifications dependent on specific 
patient encounters should be left to the treating physician.
2.3.1 History
For any child with suspicion of retinoblastoma, a very detailed history is the 
most useful step in establishing an appropriate differential diagnosis and accurate 
examination, and in cases may establish the diagnosis. History should be taken 
prior to examination to ensure an appropriate focused examination. It should 
include details of the pregnancy, labor, and delivery of the child. History of birth 
weight, birth trauma, maternal infection, history of prematurity, oxygen therapy, 
and whether leukocoria was present at birth or developed later. Also, history of 
hearing abnormalities at birth or during young childhood should be taken into 
consideration as well. History of animal/pet exposure should also be elicited. 
These questions should help direct the clinician to the diagnosis of cataract, 
retinopathy of prematurity, persistent fetal vasculature, toxocariasis, and con-
genital rubella, which all can mimic retinoblastoma. The time course of when 
parents or clinicians first noticed an abnormality and the course of their visits 
with other health care providers should be carefully elicited. Most children with 
retinoblastoma do not have an obvious ocular abnormality at birth. They tend to 
develop signs such as esotropia, visual disturbances, or other strabismus between 
6 months and 2 years of age. Leukocoria is also unlikely to be present at birth and 
will occur around the same time frame as the strabismus. For children suspected 
to have retinoblastoma a detailed family history including number and health of 
their siblings should be noted, along with any history of family medical condi-
tions. A history of poor vision, blindness, or loss of an eye should be requested. 
A positive history of retinoblastoma in parents should point to the diagnosis, as 
simulating lesions do not usually occur in patients with a positive family history. 
If the child’s parents or siblings have not had recent dilated fundus examinations 
they should be performed as soon as possible [12]. About 1% of patients with 
history of retinoblastoma may develop spontaneous regression with retinoma/
retinocytoma present on dilated examination [13]. Some parents may be unaware 
that they were treated for retinoblastoma as children and examination may be 
able to elicit this finding.
2.3.2 Office examination
The initial examination of the child should occur while history taking, by 
watching the child’s behavior, visual interaction with the world, and evaluating 
for any abnormalities in size of the child, proportions, or for any facial abnormali-
ties. The external examination of a child with retinoblastoma should be otherwise 
normal except for the ocular exam unless the child has a 13q deletion syndrome. 
Before the formal examination, the ability to notice leukocoria, decreased visual 
function, strabismus, or periorbital swelling should be noted upon gross examina-
tion. Assessment of vision is obviously dependent on age of patient, and his or her 
individual cooperation, but the size and symmetry of each eye should be recorded, 
as asymmetric size can suggest other diagnoses as well as retinoblastoma. Presence 
or absence of heterochromia should be noted during this portion of the examina-
tion as well [12]. Pupil response should also be documented. Using a direct ophthal-
moscope or retinoscope, the pupillary light reflex should be noted in both eyes and 
leukocoria can be noted at that time.
The next step should be instillation of dilating eyedrops (0.5% tropicamide and 
2.5% phenylephrine). Cyclopentolate is not necessary for this examination. If the 
Retinoblastoma - Past, Present and Future
4
child is large enough or a portable slit lamp is available, slit lamp examination should 
be performed, care to note, presence or absence of cataract, conjunctival or scleral 
injection, anterior segment shallowing, neovascularization of the iris, iris seeding 
or iris atrophy. Evaluate for retrolental membranes to assess presence of retinopathy 
of prematurity or persistent fetal vasculature. Most patients with retinoblastoma 
have normal anterior segments but may have anterior cells or nodules on the iris. 
In exophytic tumors, visualization of retinal vasculature behind the lens may be 
possible as well. Indirect ophthalmoscopy should be performed to evaluate the 
posterior pole and fundus. Depending on the age of the child, they may cooperate or 
family members may be needed to help secure the patient in a supine position. Very 
young children may be swaddled with a blanket to secure their limbs. The indirect 
exam in the office should be used to rule out simulating lesions when possible and 
to also increase or decrease suspicion for retinoblastoma, thus determining whether 
examination under anesthesia (EUA) is needed for full evaluation and diagnosis. 
An eyelid speculum may be needed for proper dilated examination, and a topical 
anesthetic such as 0.5 or 1% proparacaine should be instilled prior to speculum 
insertion. Scleral depression may be indicated, if it can be reserved for examination 
under anesthesia it is less traumatic but can be done in the office setting.
2.3.3 Ophthalmic ultrasound
An ophthalmic ultrasound can be performed in the A and B scan mode using 
a 10 mHz transducer to evaluate for intraocular masses, retinal detachment, or 
calcification. In retinoblastoma, the ultrasound should reveal an irregular mass, 
which is more echogenic than the vitreous, and commonly has fine calcifications 
(highly reflective foci mostly with acoustic shadowing) since upon histologic study, 
95% of retinoblastoma contains calcification [14] (Figure 1). Measurements should 
be taken as a baseline to compare to in the future following treatment.
2.4 Exam under anesthesia (EUA) considerations
If EUA is warranted, general anesthesia will be needed to conduct detailed 
examination and ancillary testing at one time. Preparation of the room for EUA 
should consist of examination materials including: external photography, portable 
slit lamp, tonometry, indirect ophthalmoscope with condensing lens and scleral 
Figure 1. 
10 mHz ultrasound in A and B scan mode showing a large intraocular retinoblastoma with irregular mass and 
intrinsic calcification with acoustic shadowing.
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depressor, wide-angle hand-held fundus camera, intravenous fluorescein dye, high 
resolution ophthalmic ultrasound, ultrasound biomicroscopy, electroretinogra-
phy. When retinoblastoma is confirmed, an MRI of the brain and orbits with and 
without contrast should be ordered at the time of the EUA to assess for extrascleral 
extension, orbital anatomy, posterior portion of the optic nerve, and presence of 
pinealoblastoma in trilateral disease.
2.5 Anesthesia
The type of general anesthetic and airway support varies depending on institu-
tion and available resources. Safe anesthesia methods range from mask anesthesia, 
to laryngeal mask airway (LMA), to complete endotracheal intubation. Both 
inhaled anesthetics and intravenous anesthetics, or a combination of the two, are 
suitable for examination. General guidelines recommend that heavy fatty meals be 
discontinued 8 h prior to procedure, light meals, formula, and nonhuman milk 6 h 
prior to surgery, human milk 4 h prior to anesthesia, and clear liquids 2 h prior to 
anesthesia [15]. These recommendations will vary by location and anesthesiologist, 
and type of anesthesia administered. Recently there has been literature support for 
use of LMA without placement of intravenous lines, which reduces total time under 
anesthesia without increased anesthesia complications, all of which were managed 
successfully without long term sequelae [16].
2.6 Examination under anesthesia
2.6.1 External examination
An orderly approach to the exam should be taken to efficiently access and treat 
the patient to avoid prolonged anesthesia exposure. The overall features of the 
child should be assessed, evaluating for any abnormalities that are consistent with 
retinoblastoma and a 13Q deletion syndrome which is strongly associated with 
retinoblastoma risk (Figure 2). Patient’s with 13Q deletion syndrome may have 
hypotelorism, micrognathia, hypoplasia of midface, absent nasal bones, large ears, 
hypoplastic thumbs, cleft palate, or microcephaly [17].
2.6.2 Anterior examination
Intraocular pressures should be measured using Schiotz tonometer, tonopen, 
Perkins tonometer, or pneumotonometer. Elevated intraocular pressure in patients 
with retinoblastoma can be secondary to iris neovascularization or angle closure, 
and has been associated with increased risk of optic nerve invasion and metastatic 
disease [18].
After intraocular pressure is checked, corneal diameter should be measured with 
a caliper both in horizontal and vertical directions. Conditions such as persistent 
fetal vasculature (PFV) is associated with asymmetric corneal diameter size as 
well as eyes with congenitally elevated intraocular pressures can be associated with 
buphthalmos and increased corneal diameter.
A portable slit lamp should be used to assess the anterior segment. The clini-
cian should evaluate anterior depth, clarity of the lens, neovascularization of the 
iris or atrophy, retrolental membrane, anterior chamber cells, nodules of the iris, 
or anterior vitreous seeds seen behind the lens. Presence of a pseudohypopyon 
should raise suspicion for endophytic tumor and anterior chamber seeing of cancer. 
It may be possible to visualize retinal vascular, retrolental masses, or retrolental 
membranes. Retrolental retinal tissue should reveal blood vessel branching patterns 
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extending towards the periphery of the lens which could be secondary to exophytic 
tumor, whereas the persistent tunica vasculosa lentis in PFV, vessels should be noted 
to be growing towards the center of the posterior lens in a disorganized fashion. 
Retrolental membrane without vascular pattern is suggestive of retinopathy of 
prematurity rather than RB.
Binocular indirect ophthalmoscopy should then be performed in a step by step 
fashion. Initially the vitreous should be examined in both eyes for presence of 
seeding, vitreous hemorrhage, fibrous membranes, or inflammatory debris. If the 
posterior pole is visible, optic disc and macula should be examined and abnormal 
findings documented. Examination of the periphery should be performed with 
scleral depression of the ora serrata in a clockwise or counter-clockwise fashion, 
with examination of the midperipheral retina and posterior pole for 360 degrees in 
both eyes.
Small RB lesions can be difficult to detect as there can be poor contrast between 
the small translucent tumor and the surrounding fundus. Meticulous examination 
and depression is needed to observe these tumors stereoscopically. Medium sized 
tumors become more opaque and start appearing white. Large tumors (>4–5 mm) 
in diameter will begin to have visually obvious blood supply and visually signifi-
cant feeder vessels should be noted. Many very large lesions (>6 mm) will develop 
chalky-white calcifications within the body of the tumor. The size and number of 
all tumors should be noted, with evaluation of subretinal fluid, retinal detachment, 
and presence of seeding (subretinal or vitreous) (Figure 3), and should all be 
incorporated into a detailed retinal drawing along with fundus photography [12]. 
Drawing and photography can help the clinician classify the tumor according to 
existing classification schemes at a later time.
2.6.3 Ancillary testing
2.6.3.1 Photography
It is important to obtain photographs of both the anterior segment as well as the 
vitreous cavity and posterior segment for documentation. The most useful method 
is using a wide-angle fundus camera. Photographs should be obtained during every 
EUA to help document response to therapy (Figures 4, 5A, B, and 6A, B). The 
clinician should try to standardize the photographs, so comparisons to each exam 
can be readily performed. As an example, start with a posterior pole photograph 
centered on the fovea then sequentially take peripheral photos superiorly, inferiorly, 
temporally and nasally keeping the optic nerve visible at the respective edge of the 
photograph to use as a point of reference for peripheral lesions. Then any other 
areas of special interest can be photographed separately.
Figure 2. 
External photograph of young child with leukocoria of the left eye secondary to intraocular retinoblastoma.
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2.6.3.2 Fluorescein angiography
Thanks to advances in photography as described in the above section, fluores-
cein angiography (FA) can be readily performed during an EUA and can help one 
Figure 3. 
RetCam photography of the left eye with defocusing to document free-floating vitreous seeding.
Figure 4. 
A retinoblastoma of the left eye with tumor scar showing type 3 regression.
Figure 5. 
(A) RetCam photograph of class C retinoblastoma of the right eye prior to intra-arterial chemotherapy and 
(B) RetCam photograph of the right eye showing class C retinoblastoma after treatment with intra-arterial 
chemotherapy.
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differentiate RB from simulating lesions. Firstly, subclinical neovascularization of 
the iris (NVI) can be distinguished using Retcam FA. In a recent study, eyes with 
advanced retinoblastoma, NVI was documented appearing as placoid or patchy 
areas of hyper fluorescence involving one or more sectors of the iris [19]. This find-
ing typically occurred between 1 and 2 min. Retinoblastoma in the fundus should 
show dilated and tortuous vessels, with retinal arteries which “feed” the tumor of 
the largest caliber. Also, microaneurysms, retinal hemorrhages, and arteriovenous 
shunts can also be noted. In the same study, as the tumors enlarged, the abnormal 
vascularization was no longer consistent with normal retinal anatomy, and were 
contained entirely within the tumor itself. Intrinsic vessels of the tumor had disor-
ganized and complex branching patterns, irregular caliber, and terminated early 
within the body of the tumor. This multi-level involvement of vascular abnormality 
helps the clinician readily distinguish RB from Coat’s disease which has large dilated 
vessels which remain within one level of the retina and show extensive peripheral 
non-perfusion (Figure 7A and B). Lastly, after 3 min diffuse leakage from retinal 
vessels can lead to inability to discern fine details of the fundus, so the clinician 
should try to obtain all valuable information within the first 3 min of the study.
2.6.3.3 Ophthalmic ultrasonography
During the EUA, ultrasound imaging of both eyes can be used to assess the orbit 
for extraocular extension, to measure thickness of the lesions, and to obtain axial 
lengths of the eyes to evaluate for normal size and symmetry. Ophthalmic ultrasound 
has traditionally been used for diagnosing and monitoring treatment of retinoblas-
toma and distinguishing it from simulating lesions [20, 21]. As described previously 
in the chapter, a 10 mHz transducer in the A and B scan mode should be used to image 
the posterior pole and evaluate the size and location of tumors, evaluate for retinal 
detachment, and look for extraocular extension of tumor (Figure 8). Ultrasound 
is especially useful in cases when ophthalmoscopy is limited by a poor view or in 
presence of a cataract. As described previously in this chapter, large retinoblastoma 
lesions undergo dystrophic calcification from necrosis, and these can be readily 
observed as areas of hyper-reflection with acoustic shadowing.
2.6.3.4 Ultrasound biomicroscopy
Ultrasound biomicroscopy (UBM) can also be helpful for visualizing the iris, 
pars plana, pars plicata, and ciliary body during an EUA. It is extremely helpful to 
Figure 6. 
(A) RetCam photograph of the left eye showing class D retinoblastoma prior to intra-arterial chemotherapy 
and (B) RetCam photograph of the left eye showing class D retinoblastoma after intra-arterial chemotherapy.
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assess the anterior extent of tumor burden or to obtain more information regarding 
the pars panna and ciliary body as well as anterior chamber seeding. It is especially 
important to use UBM to rule out pars plana tumor involvement in cases where 
intravitreal injections of chemotherapy are being considered to choose a proper 
injection site.
2.6.3.5 Electroretinogram
Electroretinograms (ERG) has been used to monitor retinal function before, 
during, and after therapy with intra-arterial chemotherapy. It is especially help-
ful in preverbal children who are unable to describe their level of visual function 
during the treatment course. Also it provides information regarding the cumula-
tive effects of retinal damage secondary to therapy, chemotherapy toxicity, and 
tissue destruction from treatments including radiation, laser photocoagulation, 
and cryotherapy. During the EUA, a 30-Hz flicker has been tested and shown to be 
Figure 7. 
(A) A portable wide field photograph showing a simulating lesion of retinoblastoma in the right eye 
showing a white macular lesion, close attention to the far periphery shows vascular telangiectasia  
and non-perfusion and (B) accompanying fluorescein angiogram confirming diagnosis of Coat’s  
disease in 8 year old boy, again notice vascular telangiectasias and non-perfusion within a single  
plane of the retina.
Figure 8. 
10 mHz B-scan ultrasonography of the left eye showing treated intraocular retinoblastoma with intrinsic 
calcifications and acoustic shadowing.
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informative prior to the physical examination portion of the exam [22]. One must 
be cautious to not manipulate the eyes before obtaining the ERG, as ocular manipu-
lation including scleral depression, photography, and ophthalmoscopy can affect 
the ERG readings thus confounding results [23].
2.6.3.6 Imaging for retinoblastoma
Historically computerized tomography (CT) scans were used to evaluate 
patients ocular, orbital, optic nerve, and brain involvement from the tumor, since 
CT detection of calcifications in retinoblastoma have a sensitivity of 81–96% 
and an even higher specificity [24]. Magnetic resonance imaging (MRI) however 
is currently considered to be of higher accuracy and value due to its superior 
soft-tissue contrast for determining extent of tumor into orbit, optic nerve, and 
for evaluation of the presence of pinealoblastoma in trilateral disease. CT scan-
ning is also felt to unnecessarily increase patient exposure to ionizing radiation 
with limited diagnostic value now that MRI is available. MRI of the brain and 
orbits with and without contrast is now ordered routinely on all patients with 
retinoblastoma at the time of diagnosis. The general practice among groups in the 
United States is to repeat imaging every 6–12 months for germline cases until the 
age of 5–6 years old to screen to pineal tumors. Transaxial or sagittal T1-weighted 
images will reveal an RB tumor which is slightly hyperintense with respect to 
the vitreous body. Transaxial or sagittal heavily T2-weighted imaging provides a 
low signal intensity of retinoblastoma and is helpful for detecting retinal detach-
ment. Transaxial and sagittal oblique contrast enhanced T11 weighted spin echo 
provides information of the enhancement of retinal, invasive optic nerve, invasive 
eye wall, and anterior segment lesions.
2.6.3.7 Genetic counseling
After all of the steps outlined in this chapter are followed, and a diagnosis of 
retinoblastoma is made, the clinician can hold a discussion with the family regard-
ing therapeutic options and the genetic counseling needed for the patient and their 
loved ones. A treatment plan can be devised and initiated, but is outside the scope 
of this chapter, and will be covered in other portions of this text.
3. Conclusion
Accurate and consistent diagnosis of retinoblastoma, and it’s simulating lesions 
begin with the initial consult. This involves a systematic approach starting with a 
detailed history and high level of suspicion for patients presenting with leukocoria, 
decreased vision, strabismus, periorbital swelling, or dysmorphic facial features. 
Initial examination should involve a detailed dilated fundus exam with ophthalmic 
ultrasound, which will either push the clinician towards or away from the diagnosis 
of retinoblastoma. Any suspicion should warrant an examination under anesthesia 
as outlined above to obtain all of the information needed for an accurate diagnosis. 
The examination under anesthesia should follow a consistent, careful, and repeat-
able fashion as described earlier in the chapter. The techniques above, if followed, 
should aid the clinician in consistent diagnosis of retinoblastoma and its simulating 
lesions. Once diagnosed, appropriate brain and body imaging, and referral for 
genetic counseling should be performed. Treatment of this rare condition, along 
with survival and preservation of the eye is continuing to improve and will be 
covered in other portions of this text.
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